checkAd
    Startseite > Aktien > CymaBay Therapeutics > Nachrichten
    CymaBay Therapeutics Aktie
    30,00
     
    EUR
    +0,67 %
    +0,20 EUR
    Letzter Kurs 21.03.24 Tradegate
    29,20
     
    EUR
    137 STK
    Geldkurs 21.03.24
    30,80
     
    EUR
    129 STK
    Briefkurs 21.03.24
    ISIN: US23257D1037 · WKN: A116DD · SYM: C0I · USA

    Neueste Nachrichten

    Gilead Sciences Announces Completion of Acquisition of CymaBay
    22.03.24 · Business Wire (engl.) · Gilead Sciences
    Fokus Aktien mit extremen Handelsvolumen am Montag, den 04.03.2024
    04.03.24 · wO Chartvergleich · Myriad Genetics
    CymaBay Announces European Medicines Agency Accepts for Review the Marketing Authorization Application for Seladelpar for the Treatment of Primary Biliary Cholangitis
    04.03.24 · globenewswire · CymaBay Therapeutics
    CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update
    28.02.24 · globenewswire · CymaBay Therapeutics
    CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    20.02.24 · globenewswire · CymaBay Therapeutics
    CYMABAY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CymaBay Therapeutics, Inc. - CBAY
    16.02.24 · Business Wire (engl.) · CymaBay Therapeutics
    Biotech-Übernahme: US-Biotechkonzern Gilead kauft Konkurrenten CymaBay in Milliarden-Deal
    12.02.24 · wallstreetONLINE Redaktion · Gilead Sciences
    CBAY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CymaBay Therapeutics, Inc. Is Fair to Shareholders
    12.02.24 · Business Wire (engl.) · CymaBay Therapeutics
    Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics
    12.02.24 · Business Wire (engl.) · Gilead Sciences
    CymaBay Therapeutics to Participate in Upcoming Investment Conferences
    31.01.24 · globenewswire · CymaBay Therapeutics
    CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    16.01.24 · globenewswire · CymaBay Therapeutics
    CymaBay Therapeutics to Present at the 42nd Annual JP Morgan Healthcare Conference 2024
    02.01.24 · globenewswire · CymaBay Therapeutics